Pages that link to "Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial"
Jump to navigation
Jump to search
The following pages link to Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial:
Displayed 2 items.
- Acronyms of Clinical Trial Names (← links)
- APPRAISE-1 (redirect page) (← links)